The earnings call reflected a strong overall performance for Oscar Health in 2024, marked by record revenue, profitability, and membership growth. While there were minor challenges related to the medical loss ratio and fourth-quarter losses, the company's strategic advancements in technology and operational efficiencies, along with significant growth metrics, demonstrate a positive trajectory going into 2025.

Company Guidance

During Oscar Health's fourth quarter and full year 2024 earnings call, the company reported significant financial milestones, achieving total company adjusted EBITDA profitability of $199 million and net income profitability of $25 million. Revenue surged by 57% year-over-year to $9.2 billion, driven by a 37% growth in membership, outpacing the individual market's 13% growth. The medical loss ratio was stable, increasing slightly by 10 basis points to 81.7%, while the SG&A ratio improved by over 500 basis points to 19.1%. Looking ahead, Oscar projects total revenues for 2025 to be between $11.2 billion and $11.3 billion, with a medical loss ratio improvement of 50 basis points at the midpoint and an SG&A ratio improvement by approximately 125 basis points. The company aims for earnings from operations to range between $225 million and $275 million, with an anticipated positive net income for 2025. Oscar is committed to delivering a 20% revenue CAGR and a 5% operating margin by 2027.

Record Financial Performance

Oscar Health reported the strongest financial performance in its history with total company adjusted EBITDA growing to $199 million, a $245 million year-over-year improvement, and achieving net income profitability with a $25 million net income, a $296 million increase over the prior year.

Significant Revenue Growth

Total revenue increased by 57% year-over-year to $9.2 billion, driven by record high membership and strong retention.

Improved SG&A Ratio

The SG&A ratio improved by more than 500 basis points year-over-year to 19.1% through operating leverage and disciplined expense management.

Membership Growth

Oscar's membership grew by 37%, outpacing the market growth of 13%, with 1.8 million members as of February 1, 2025.

Technology and AI Advancements

Oscar's technology platform and AI integration improved operational efficiency, member engagement, and affordability, with applications reducing provider tasks and implementation time.

---

Oscar Health (OSCR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OSCR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
May 13, 2025	2025 (Q1)	0.81 / -	0.62	―	―	―
Feb 04, 2025	2024 (Q4)	-0.59 / -0.62	-0.66	6.06% (+0.04)	―
Nov 07, 2024	2024 (Q3)	-0.17 / -0.22	-0.29	24.14% (+0.07)	―
Aug 07, 2024	2024 (Q2)	0.16 / 0.20	-0.07	385.71% (+0.27)	―
May 07, 2024	2024 (Q1)	0.27 / 0.62	-0.18	444.44% (+0.80)	―
Feb 07, 2024	2023 (Q4)	-0.72 / -0.66	-1.05	37.14% (+0.39)	―
Nov 07, 2023	2023 (Q3)	-0.47 / -0.29	-0.91	68.13% (+0.62)	―
Aug 08, 2023	2023 (Q2)	-0.22 / -0.07	-0.53	86.79% (+0.46)	―
May 09, 2023	2023 (Q1)	-0.06 / -0.18	-0.36	50.00% (+0.18)	―
Feb 09, 2023	2022 (Q4)	-1.14 / -1.05	-0.95	-10.53% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

OSCR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 04, 2025	$15.28	$15.75	+3.08%
Nov 07, 2024	$15.55	$13.64	-12.28%
Aug 07, 2024	$17.23	$16.70	-3.08%
May 07, 2024	$18.97	$19.77	+4.22%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---